Document Type

Article

Publication Date

4-1-2022

Publication Title

Otolaryngologic clinics of North America

Abstract

Prolactinomas are the most common secretory tumor of the pituitary gland. Clinical symptoms may be due to prolactin oversecretion, localized mass effect, or a combination of both. Although the mainstay of prolactinoma management is medical therapy with dopamine agonists, endoscopic endonasal or transcranial surgery, radiation therapy, or a combination of these is an important treatment option in select cases. This article discusses prolactinoma phenotypes, clinical presentations, and clinically pertinent medical and surgical considerations when managing these tumors.

Medical Subject Headings

Dopamine Agonists; Humans; Nose; Pituitary Neoplasms; Prolactin; Prolactinoma

PubMed ID

35256169

ePublication

ePub ahead of print

Volume

55

Issue

2

First Page

305

Last Page

314

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.